You are being redirected because this document is part of your ASTM Compass® subscription.
    This document is part of your ASTM Compass® subscription.

    Volume 22, Issue 1 (January 1977)

    Intravenous Abuse of Propylhexedrine

    (Received 2 April 1976; accepted 27 April 1976)

    Published Online: 1977


      Format Pages Price  
    PDF (484K) 7 $25   ADD TO CART

    Cite this document

    X Add email address send
      .RIS For RefWorks, EndNote, ProCite, Reference Manager, Zoteo, and many others.   .DOCX For Microsoft Word


    The Benzedrex® nasal inhaler is an over-the-counter device used for the symptomatic treatment of nasal congestion resulting from head colds and hay fever. The active ingredient is propylhexedrine, a local vasoconstrictor. While only two deaths due to propylhexedrine are in the medical literature [1], abuse of the drug occurs with greater frequency than realized. Since 1974, the Dallas County Criminal Investigation Laboratory has detected propylhexedrine in syringes in twelve cases submitted by local police agencies. In a recent six-month period, the Office of the Medical Examiner for Dallas County has encountered three deaths resulting from intravenous injection of propylhexedrine as well as two deaths from other causes in which the deceased had been injecting this drug. Two of the individuals dying of propylhexedrine abuse showed vascular changes in the lungs, apparently caused by chronic intravenous injection of this drug.

    Author Information:

    Garriott, JC
    Chief toxicologist, Southwestern Institute of Forensic Sciences, Dallas, Tex.

    DiMaio, VJM
    Medical examiner, Southwestern Institute of Forensic Sciences, Dallas County, Tex.

    Stock #: JFS10380J


    DOI: 10.1520/JFS10380J

    Title Intravenous Abuse of Propylhexedrine
    Symposium ,
    Committee E30